含有Ca2+和cGAMP的半导体聚合物纳米信件用于放射动态激活过载和免疫治疗
Danling Cheng1, Libai Luo2, Qin Zhang3
1Institute of Immunology, Zhejiang University School of Medicine, Hangzhou, 310009, China.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|December 16, 2024
概括
这项研究引入了一种用于转移性乳腺癌的新型纳米信使,它结合了离子和cGAMP. 由X射线激活,它向瘤,增强免疫力,并抑制癌症生长和转移.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术纳米技术
- 癌症治疗 癌症治疗
背景情况:
- 第二信使在生物系统中至关重要,但它们在癌症治疗中的疗效需要改进.
- 转移性乳腺癌需要先进的治疗策略才能有效治疗.
研究的目的:
- 开发一种新型的半导体聚合物纳米传递器 (TCa/SPN/a) 用于转移性乳腺癌治疗.
- 使用离子 (Ca2+) 和循环氨酸单酸盐-氨酸单酸盐 (cGAMP) 创建一个双功能的纳米疗法.
主要方法:
- 构建的TCA/SPN/a能够对X射线做出反应,以有针对性地输送Ca2+和cGAMP.
- 利用X射线辐射诱导放射动力学效应,产生单片氧 (O2) 用于瘤切除和免疫细胞死亡 (ICD).
- 研究了针对线粒体的Ca2+化合物用于ROS生成和cGAMP用于STING通路激活.
主要成果:
- TCa/SPN/a证明了X射线激活的单片氧生成用于瘤切除和增强免疫性.
- 针对线粒体的Ca2+诱导过载,ROS生成和线粒体损伤.
- cGAMP激活了STING通路,增强了免疫效应.
- 该纳米疗法显著抑制了瘤生长,并消除了小鼠模型中的转移.
结论:
- TCa/SPN/a代表了第一个智能双功能纳米治疗药物,它包含两个秒信使,用于精确的癌症治疗.
- 这种方法结合了放射动力疗法,过载和免疫疗法,以有效治疗转移性乳腺癌.
更多相关视频
08:41Monitoring Endoplasmic Reticulum Calcium Homeostasis Using a Gaussia Luciferase SERCaMP
Published on: September 6, 2015
13.1K
11:20An Integrated System to Remotely Trigger Intracellular Signal Transduction by Upconversion Nanoparticle-mediated Kinase Photoactivation
Published on: August 30, 2017
7.4K
相关概念视频
Calmodulin-dependent Signaling
5.1K
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
5.1K
Amplifying Signals via Second Messengers
6.7K
Many receptor binding ligands are hydrophilic; they do not cross the cell membrane but bind to cell-surface receptors. Thus, their message must be relayed by second messengers present in the cell cytoplasm. There are several second messenger pathways, each with its own way of relaying information. For example, the G protein-coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol pathway is active when the receptor induces...
6.7K
